Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-20

Clinical Trial Update: The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the efficacy and safety of quetiapine XR in schizophrenia patients who were switched from other antipsychotics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED